Aldehyde Dehydrogenase 3 Family Member A2 (ALDH3A2) Antibody

Este producto es parte de ALDH - Aldehyde dehydrogenase family member
Product Graph
455€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Aldehyde Dehydrogenase 3 Family Member A2 (ALDH3A2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx159324
tested applications
ELISA, WB

Description

ALDH3A2 Antibody is a Mouse Monoclonal against ALDH3A2.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Aldehyde Dehydrogenase 3 Family Member A2 (ALDH3A2)
Host
Mouse
Reactivity
Human, Mouse, Rat, Rabbit
Recommended Dilution
WB: 1/500 - 1/5000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
Unconjugated
Isotype
IgG2a
Purification
Purified by affinity chromatography.
Size 1
100 µl
Form
Liquid
Tested Applications
ELISA, WB
Buffer
0.1M Tris-Glycine (pH 7.4, 150 mM NaCl) with 0.2% sodium azide, 50%,glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P51648
Alias
ALDH3A2,ALDH10,FALDH
Background
Antibody anti-ALDH3A2
Status
RUO

Descripción

ALDH3A2, also known as fatty aldehyde dehydrogenase (FALDH), is a key enzyme that catalyzes the oxidation of fatty aldehydes to fatty acids. This process is essential for lipid metabolism, particularly in the breakdown of long-chain and very-long-chain fatty aldehydes derived from sphingolipids and dietary fats. Mutations in ALDH3A2 cause Sjögren-Larsson Syndrome (SLS), a rare autosomal recessive disorder characterized by ichthyosis (skin scaling), spasticity, and intellectual disability due to the accumulation of fatty aldehydes and disruption of lipid homeostasis. ALDH3A2 is expressed in the liver, brain, and skin, where it supports lipid metabolism and protects against oxidative stress. Its role in maintaining cellular membrane integrity and energy balance highlights its importance in metabolic and neuroprotective functions. Therapies targeting ALDH3A2 aim to restore fatty acid metabolism and alleviate symptoms of SLS, emphasizing its role in lipid-mediated pathologies.

Related Products

FNab00293

anti- ALDH3A2 antibody

Catalyzes the oxidation of long-chain aliphatic aldehydes to fatty acids. Active on a variety of saturated and unsaturated aliphatic aldehydes between 6 and 24 carbons in length. Responsible for conversion of the sphingosine 1-phosphate(S1P) degradation product hexadecenal to hexadecenoic acid.

Ver Producto
P9278

Recombinant Human ALDH3A2

Ver Producto
abx025200

Fatty Aldehyde Dehydrogenase (ALDH3A2) Antibody

Aldehyde dehydrogenase isozymes are thought to play a major role in the detoxification of aldehydes generated by alcohol metabolism and lipid peroxidation. This gene product catalyzes the oxidation of long-chain aliphatic aldehydes to fatty acid. Mutations in the gene cause Sjogren-Larsson syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. This antibody is supplied as crude ascites.

Ver Producto